NIFTY 50▼25,370.30
-18.60 (-0.07%)
SENSEX▼82,947.64
-15.07 (-0.02%)
NIFTY BANK▲51,885.85
113.45 (0.22%)
TATA MOTORS▲991.00
4.85 (0.49%)
SUZLON ENERGY▲83.26
1.56 (1.91%)
INDIAN RAILWAY FINANCE CORP▲167.29
0.27 (0.16%)
TATA STEEL▲154.09
2.35 (1.55%)
TATA POWER▲442.70
2.80 (0.64%)
RAIL VIKAS NIGAM▲554.80
2.80 (0.51%)
INDIAN RENEWABLE ENERGY▼232.01
-0.63 (-0.27%)
RELIANCE INDUSTRIES▼2,956.95
-2.65 (-0.09%)
VODAFONE IDEA▲13.53
0.01 (0.07%)
ZOMATO▼274.25
-9.65 (-3.40%)
ADANI POWER▼636.65
-14.45 (-2.22%)
YES BANK▲23.61
0.18 (0.77%)
NHPC▲95.48
0.18 (0.19%)
RELIANCE POWER▲29.90
0.23 (0.78%)
STATE BANK OF INDIA▲794.00
6.25 (0.79%)
HDFC BANK▼1,658.85
-7.75 (-0.47%)
JIO FIN SERVICES LTD▼347.90
-1.90 (-0.54%)
ADANI PORT & SEZ▼1,452.90
-19.70 (-1.34%)
BHARAT ELECTRONICS▼291.10
-0.60 (-0.21%)
GTL INFRA▼2.55
-0.03 (-1.16%)
INDIAN OIL CORP▲173.70
0.44 (0.25%)
MRF▲1,37,273.80
1311.55 (0.96%)
OLA ELECTRIC MOBILITY LTD▲112.73
0.09 (0.08%)
INDIAN RAILWAY TOURISM CORP▲941.90
10.55 (1.13%)
RATTANINDIA POWER▼15.43
-0.05 (-0.32%)
Mankind Pharma Share Price
MANKIND
₹2,484.50+₹53.10 (2.18%) TodayLast updated on 13 Sep, 2024 | 13:19 IST
Please wait...
What’s in news?
Company overview
Financial performance
Market cap
| Open₹2,448.40 | Close₹2,431.40 |
Circuit range₹2,917.65 - ₹1,945.15 | Day range₹2,448.00 - ₹2,564.95 | Year range₹1,683.05 - ₹2,564.95 |
Volume8,13,205 | Avg. traded₹2,500.38 | Revenue (12m)₹10,650 Crs |
Mankind PharmaMankind Pharma Limited is an India-based pharmaceutical company. It is engaged in developing, manufacturing, and marketing a range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products. It offers healthcare solutions for a range of healthcare needs with a portfolio that includes anti-infectives, cardiovascular, gastrointestinal, anti-diabetic, neuro/ central nervous system, vitamins, minerals and nutrients and respiratory therapies. Its portfolio of brands includes Nurokind, Telmikind, Manforce (Rx), Gudcef, Moxikind, Amlokind, Glimestar, Asthakind, Codistar, Candiforce, Mahacef, Dydroboon, Cefakind, Zenflox, Monticope, Dynaglipt, and others. Its branded product portfolio spans women’s health, fertility and critical care, with several brands in their respective therapy areas. Its subsidiaries include Lifestar Pharma Private Limited, Magnet Labs Private Limited, Jaspack Industries Private Limited, and others.
Mankind Pharma Key indicators
52 week high₹2,564.95 | 52 week low₹1,683.05 | P/E ratio49.74 |
P/B ratio9.86 | ROE20.98% | ROCE26.13% |
Dividend yield-- | Debt/Equity ratio | EPS45.52 |
Learn more
Featured in
Investment checklist: (3/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Analyst ratings:
Analyst ratings:
64%
Hold
27%
Sell
9%
This analysis is based on the reviews of 11 experts in the last 7 days
Fundamentals
Financial ratios
Operating profit margin26.94% | Net profit margin18.95% |
ROE20.98% | ROA17.54% |
ROCE26.13% |
Learn more
Mankind Pharma Share Price history
Day | Open | Close | Day’s change |
---|---|---|---|
Thu, Sep 12 2024 | ₹2,443.05 | ₹2,431.40 | -0.06% |
Wed, Sep 11 2024 | ₹2,448.00 | ₹2,432.75 | -0.63% |
Tue, Sep 10 2024 | ₹2,454.30 | ₹2,448.15 | |
Mon, Sep 9 2024 | ₹2,466.00 | ₹2,411.95 | -0.47% |
Fri, Sep 6 2024 | ₹2,480.20 | ₹2,423.35 | -2.01% |
Thu, Sep 5 2024 | ₹2,415.00 | ₹2,473.15 | |
Wed, Sep 4 2024 | ₹2,392.00 | ₹2,413.70 | |
Tue, Sep 3 2024 | ₹2,412.85 | ₹2,391.10 | -0.00% |